ストックスクリーナーアプリを入手
1.70
2.41%
0.04
Vigil Neuroscience Inc (VIGL) 最新ニュース
Vigil Neuroscience, Inc. (NASDAQ:VIGL) Director Haeberlein Samantha L. Budd Purchases 12,000 Shares - MarketBeat
Vigil Neuroscience director Budd Haeberlein buys $20,520 in shares - Investing.com
Vigil neuroscience CEO Ivana Magovcevic-Liebisch acquires $8,350 in stock - Investing.com India
Vigil neuroscience CEO Ivana Magovcevic-Liebisch acquires $8,350 in stock By Investing.com - Investing.com Australia
Vigil Neuroscience stock hits 52-week low at $2.07 - Investing.com India
Vigil Neuroscience stock hits 52-week low at $2.07 By Investing.com - Investing.com South Africa
Vigil Neuroscience (NASDAQ:VIGL) and ProKidney (NASDAQ:PROK) Head-To-Head Contrast - Defense World
Vigil Neuroscience initiated with an Outperform at William Blair - MSN
FY2024 Earnings Estimate for VIGL Issued By William Blair - MarketBeat
FY2024 Earnings Forecast for VIGL Issued By William Blair - Defense World
SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of Vigil Neuroscience, Inc. (NASDAQ: VIGL) - The Eastern Progress Online
William Blair Initiates Coverage on Vigil Neuroscience (NASDAQ:VIGL) - Defense World
Vigil neuroscience CEO Ivana Magovcevic-Liebisch buys $11,700 in stock By Investing.com - Investing.com Australia
Vigil neuroscience CEO Ivana Magovcevic-Liebisch buys $11,700 in stock - Investing.com
William Blair Initiates Coverage of Vigil Neuroscience (VIGL) with Outperform Recommendation - MSN
William Blair initiates Vigil Neuroscience with Outperform By Investing.com - Investing.com Nigeria
William Blair initiates Vigil Neuroscience with Outperform - Investing.com
Vigil Neuroscience shares rated Outperform by William Blair, advancing in Alzheimer's treatment - Investing.com Nigeria
Vigil Neuroscience: Down On A Competitor's Failure (NASDAQ:VIGL) - Seeking Alpha
Contrasting Vigil Neuroscience (NASDAQ:VIGL) and Surrozen (NASDAQ:SRZN) - Defense World
Vigil Neuroscience, Inc. (NASDAQ:VIGL) Short Interest Update - MarketBeat
JMP Securities Reiterates Market Outperform Rating for Vigil Neuroscience (NASDAQ:VIGL) - Defense World
Guggenheim maintains Buy on Vigil Neuroscience stock post-Alector trial By Investing.com - Investing.com Canada
Vigil Neuroscience stock hits 52-week low at $2.45 - Investing.com India
Vigil Neuroscience stock hits 52-week low at $2.45 By Investing.com - Investing.com UK
Guggenheim maintains Buy on Vigil Neuroscience stock post-Alector trial - Investing.com
Vigil Neuroscience's (VIGL) Market Outperform Rating Reiterated at JMP Securities - MarketBeat
Citadel Advisors LLC Adjusts Position in Vigil Neuroscience Inc - GuruFocus.com
Vigil Neuroscience, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Deep Track Capital, LP Increases Stake in Vigil Neuroscience Inc - GuruFocus.com
Vigil Neuroscience to Present at Upcoming Investor Conferences - GlobeNewswire
Vigil Neuroscience Reports Third Quarter 2024 Financial Results and Provides Business UpdateOn November 7, 2024, Vigil Neuroscience, Inc. (NASDAQ: VIGL) released its financial results for the third quarter ended September 30, 2024. The company, dedic - Defense World
Vigil Neuroscience’s (VIGL) “Buy” Rating Reiterated at HC Wainwright - Defense World
Vigil Neuroscience (NASDAQ:VIGL) Price Target Raised to $24.00 - Defense World
Vigil Neuroscience (NASDAQ:VIGL) Given New $24.00 Price Target at Wedbush - MarketBeat
HC Wainwright Reiterates Buy Rating for Vigil Neuroscience (NASDAQ:VIGL) - MarketBeat
Vigil Neuroscience Advances Key Clinical Programs - TipRanks
Vigil Neuroscience Reports Third Quarter 2024 Financial Results and Provides Business Update - GlobeNewswire
Vigil Neuroscience, Inc. (NASDAQ:VIGL) has caught the attention of institutional investors who hold a sizeable 41% stake - Yahoo Finance
Vigil Neuroscience to Present at Guggenheim Healthcare Innovation Conference - GlobeNewswire
abrdn plc Makes New $799,000 Investment in Vigil Neuroscience, Inc. (NASDAQ:VIGL) - MarketBeat
We Think Vigil Neuroscience (NASDAQ:VIGL) Needs To Drive Business Growth Carefully - Simply Wall St
Vigil Neuroscience retains stock target on TREM2 potential - Investing.com
Vigil Neuroscience retains stock target on TREM2 potential By Investing.com - Investing.com Australia
Quanterix Welcomes Ivana Magovčević-Liebisch, Ph.D., J.D. to Board of Directors - BioSpace
Quanterix Appoints Ivana Magovčević-Liebisch to Board of Directors - citybiz
Point72 Asset Management L.P. Buys New Position in Vigil Neuroscience, Inc. (NASDAQ:VIGL) - Defense World
2.88%
2.65%
大文字化:
|
ボリューム (24 時間):